Metro
AJC DETROIT PRESENTS AN EVENING WITH
Elizabeth Bettina
t Ni-01.t) s . rt,ittc,
AND
(,I
11 ■41N% rtIF.
PEA ■ 1•1.1: OF
Ursula Korn-Selig
11 NIA DFFIF.1%
rlle
"4.1s.
111)11,114.411 ,+
TtIC 11c)1.1.11. NI SI
Women With Advanced
Breast Cancer Sought
"It Happened in Italy"
Untold stories of how the people of Italy
defied the Horrors of the Holocaust
Monday, November 30, 2009 7:30 - 9:00 PM
S
Holocaust Memorial Center
Cosponsored by: Holocaust Memorial Center, Archdiocese
of Detroit, JCC, and the Italian Consulate in Detroit
$20 Couvert, includes dessert reception
RSVP to detroit@ajc.org or 248.646.7686
‘111110
American
Jewish
Committee
1551950
"DESIGNS IN DECORATOR WOOD & LAMINATES, LTD.
It Doesn't Have To Cost ortunemOnly Look Like it!
t. Joseph Mercy Oakland
(SJMO) is seeking women with
triple negative breast cancer
to participate in a clinical trial through
Saint Joseph Mercy Health System
at St. Joseph Mercy Oakland, 44405
Woodward Ave., Pontiac. St. Joseph
Mercy Ann Arbor also is participating
in the trial.
The trial is to test a novel drug in
the treatment of an aggressive form of
breast cancer that has spread beyond
the breast. The hospitals seek women
with advanced breast cancer to test an
experimental targeted drug, BSI 201.
When used with traditional chemo-
therapy that damages the cancer cell's
DNA, the trial drug selectively blocks a
cancer cell's ability to repair itself and
causes the cancer cell to die.
To participate in the trial, patients
must have metastatic triple negative
breast cancer, have completed no more
than two rounds of chemotherapy
treatment and have disease that is mea-
surable on an imaging study.
Involved in the trial is SJMO's medi-
cal director of oncology services, Dr.
Judie Goodman.
For more information, call the
Michigan Cancer Research Consortium,
(877) 590-5995. I 1
Study Investigating
Alzheimer Treatment
T
Complete kitchen and bathroom remodeling as well as furniture
design and installations including granite, wood and other materials.
Lois Huron Allied Member ASID 248.851.6989
Send your college student news from home!
College kids love news from home - the JN will
help keep them in touch with everything that is
happening while they are away!
he Ann Arbor-based Mood &
Memory Clinic of Michigan
has begun enrolling patients
with Alzheimer's disease in the
CONCERT study, a new clinical trial
that will test the efficacy of the inves-
tigational drug dimebon (latrepirdine)
in patients currently taking Aricept
(donepezil HCI tablets), an Alzheimer's
disease medication worldwide.
"Alzheimer's is a complex disease
and while current medications address
symptoms for some patients, the dis-
ease often requires combination ther-
apy to maximize clinical benefit," said
Stephen Aronson, M.D., CONCERT
investigator. "CONCERT is an impor-
tant study because dimebon is thought
to work differently than current medi-
cations and this study will evaluate
whether adding it to one of the most
commonly used Alzheimer's medi-
cations will provide more effective
symptomatic treatment to patients."
While a cure is still many years away,
treatments that provide lasting effects,
more complete symptomatic benefits
or slow disease progression would be
meaningful advances for patients and
caregivers; for this reason there is an
urgent need for patients to participate
in clinical trials to help advance the
understanding of how Alzheimer's dis-
ease can be better treated.
According to estimates from the
Alzheimer's Association, 5.3 million
people in the United States are liv-
ing with Alzheimer's, a devastating
disease that hinders a patient's ability
to remember, learn, perform daily
activities and relate to others. As the
baby boomer population ages, the
incidence of Alzheimer's is expected
to increase dramatically.
CONCERT is an international, ran-
domized, placebo-controlled study that
will enroll 1,050 patients with mild-to-
moderate Alzheimer's disease at 100
sites in the United States, Australia, New
Zealand and Western Europe.
For more information on eligibility
and enrollment, patients and caregiv-
ers can call Ellen Near at (734) 973-
9700 or the CONCERT study hotline
toll-free at (877) 888-6386, or visit
www.concertstudy.com. Fl
Call us today and we'll take care of the rest
New Book On ADHD
800.875.6621
-
S E
itkedigAizZeiT7.
$20 per year
*10 months • In-state only • Call for out of state special rates
Visit theJEWISHNEWS.com
18
November 12 • 2009
JN
Dr. Joel Young of West Bloomfield,
medical director and founder of
the Rochester Center for Behavioral
Medicine, has released his second
book on Adult Attention Deficit/
Hyperactivity disorder.
Contemporary Guide to Adult ADHD,
now in publication by Handbooks in
Healthcare, offers a comprehensive
look at the diagnosis.
The book is available at hhcbooks.
corn and amazon.com .